817 related articles for article (PubMed ID: 29847487)
1. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
[TBL] [Abstract][Full Text] [Related]
2. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Reinhart M; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
[TBL] [Abstract][Full Text] [Related]
3. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
5. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
6. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Turnbull F;
Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
8. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Neal B; MacMahon S; Chapman N;
Lancet; 2000 Dec; 356(9246):1955-64. PubMed ID: 11130523
[TBL] [Abstract][Full Text] [Related]
9. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacies of antihypertensive drugs.
Aursnes I; Tvete IF; Gåsemyr J; Natvig B
Scand Cardiovasc J; 2003 May; 37(2):72-9. PubMed ID: 12775305
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
Morgan TO; Anderson AI; MacInnis RJ
Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
[TBL] [Abstract][Full Text] [Related]
12. Are there benefits to specific antihypertensive drug therapy?
Cushman WC
Am J Hypertens; 2003 Nov; 16(11 Pt 2):31S-35S. PubMed ID: 14625158
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.
Staessen JA; Wang JG; Thijs L
J Hypertens; 2003 Jun; 21(6):1055-76. PubMed ID: 12777939
[TBL] [Abstract][Full Text] [Related]
14. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
15. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.
Brewster LM; van Montfrans GA; Oehlers GP; Seedat YK
Intern Emerg Med; 2016 Apr; 11(3):355-74. PubMed ID: 27026378
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
17. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
[TBL] [Abstract][Full Text] [Related]
18. Conventional therapy and newer drug classes for cardiovascular protection in hypertension.
Wang JG; Staessen JA
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S208-15. PubMed ID: 12466316
[TBL] [Abstract][Full Text] [Related]
19. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
Law MR; Morris JK; Wald NJ
BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
[TBL] [Abstract][Full Text] [Related]
20. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]